Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27083448 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Xinyi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Hauptthemen laut MEDLINE: Arachidonate 15-Lipoxygenase, Antiviral Agents, Lipoxygenase Inhibitors, Viral Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Province Technology Innovation Guidance Program (Central Guided Local Science and Technology Development Fund, Jinan "20 New Universities" Funding Project, Shandong Traditional Chinese Medicine Science and Technology Project.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is a major pathogen responsible for severe lower respiratory tract infections in infants, the elderly, and immunocompromised individuals. Because the RSV F protein mediates viral entry and 15-lipoxygenase (15-LOX) amplifies virus-induced inflammatory responses, dual targeting of these proteins may provide both antiviral and anti-inflammatory benefits. In this study, we combined computational prediction with experimental validation to identify natural dual-target inhibitors from the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP). A total of 13,131 natural compounds were screened by drug-likeness evaluation, molecular docking, ADME assessment, and molecular dynamics simulations, yielding 31 potential dual-target candidates with favorable drug-like properties. Among them, rhoeadine (MOL001473) maintained stable binding conformations with both targets throughout 100 ns simulations. In BEAS-2B cells, rhoeadine exhibited significant anti-RSV activity (EC50 = 1.82 µM), low cytotoxicity (IC50 = 34.50 µM), and a selectivity index (SI) of 18.97. Time-of-addition experiments suggested that rhoeadine primarily acts at the early stage of viral infection. Additionally, ELISA results indicated that rhoeadine significantly inhibited RSV-induced secretion of CCL5 and IL-6, highlighting its anti-inflammatory potential. In summary, this study identified rhoeadine as a promising natural compound with antiviral and anti-inflammatory activities against RSV. Computational analyses suggested its potential association with RSV F protein and 15-LOX, although direct target-level validation is still required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
- Shandong Academy of Chinese Medicine, Jinan 250014, China.
Förderung
- Shandong Province Technology Innovation Guidance Program (Central Guided Local Science and Technology Development Fund
- Jinan "20 New Universities" Funding Project
- Shandong Traditional Chinese Medicine Science and Technology Project
- Medicine State Administration : Mechanism analysis of Huangbai Liniment
- Shandong Provincial Natural Science Foundation
- Shandong Province Technology Innovation Guidance Program
- Jinan “20 New Universities” Funding Project
- Chinese Medicine State Administration: Mechanism analysis of Huangbai Liniment
Zitieren
APA
Zhou, X., Du, H., Wang, C., Zhang, M., Ding, X., Wang, Y., Fan, Z., & Wang, P. (2026). Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27083448
Vancouver
Zhou X, Du H, Wang C, Zhang M, Ding X, Wang Y, et al. Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27083448
BibTeX
@article{Zhou2026,
author = {Zhou, Xinyi and Du, Haitao and Wang, Cheng and Zhang, Mengru and Ding, Xiaoyan and Wang, Yi and Fan, Zhonghao and Wang, Ping},
title = {Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27083448}
}
EUVIMED